Andrew Darmos

[InvestAnswers @Investanswers]

UNSUPERVISED ROBOTAXIS GOING VERTICAL! 🚕📈
Despite earnings call, data is screaming BULLISH: unsupervised cars up 50% in just days.
Once Safety is locked in - Tesla can flip the switch and add thousands on the road overnight.
#Tesla #Robotaxi #FSD

[Herbert Ong @herbertong]

🚨 Tesla’s Robotaxi fleet has grown to 640 vehicles

• Supervised: 621
• Unsupervised: 19

Breakdown:
• Bay Area: 538
• Austin: 98
• Dallas: 2
• Houston: 2

The fleet is growing, and unsupervised is slowly scaling. $TSLA

via @RtaxiTracker

[TechOperator @TechOperator]

Presenting VIN Zero — the very first production Cybercab built at Giga Texas.

[Redacted @RedactedNews]

Shocking research reveals ivermectin & mebendazole may target cancer stem cells, disrupt microtubules, and starve tumors of glucose. Is there a hidden link between parasitic infections and cancer?

[Teslaconomics @Teslaconomics]

It boggles my mind that the LEAST exciting thing about the next-gen Tesla Roadster is going to be going 0 to 60 mph in 1 second…

This has to be the most exciting product unveil ever.

[John F Kennedy Jr @John_F_kJr]

🚨 BOMBSHELL ALERT: First-in-the-World IVERMECTIN, Mebendazole, and Fenbendazole Protocol for CANCER Has Been Peer-Reviewed and Published – BIG PHARMA TREMBLES

🚨 EXPOSED: A peer-reviewed study confirms that the banned drugs Ivermectin, Fenbendazole, and Mebendazole obliterate cancer cells — and Big Pharma is LOSING ITS MIND. The truth is out. Their billion-dollar lie is collapsing, and the panic is very, very real.

🚨 FIRST-IN-THE-WORLD #IVERMECTIN, #MEBENDAZOLE, AND #FENBENDAZOLE PROTOCOL IN CANCER

FOLLOW ME, THE NEXT DROP WILL BE SHOCKING.

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression

After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️

We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

@twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Elon Musk @elonmusk]

FSD 14.3 release notes @Tesla_AI

[Teslaconomics @Teslaconomics]

This is exactly why I will NEVER put my kids in anything but a Tesla

[TheSonOfWalkley @TheSonOfWalkley]

BREAKING: CATHIE WOOD SAYS — ELON MUSK WILL “REWARD” $TSLA INVESTORS WITH ROBOTAXI TAKEOFF 👀

She says patience will be rewarded !

[Pejjy @CuriousPejjy]

$TSLA down nearly 20% while:

- Robotaxi are now 500+ operational and growing rapidly.
- FSD Unsupervised about to roll out.
- FSD take-rate growing.
- FSD to enter Europe
- FSD to enter China.
- Cybercab mass production next month.
- Optimus Gen 3 unveil next month.
- Energy growing 50% YOY.
- Semi about to enter mass production.
- Elon hinting at a new vehicle.
- Roadster unveil next week.

I don't know about you, but putting aside the noise, it looks like a damn good buying opportunity!

NFA.

[Elon Musk @elonmusk]

That will be one hell of a building!

[Herbert Ong @herbertong]

🚨 Elon Musk on Tesla Optimus at the 2026 Abundance Summit:

"We will start production on Optimus 3 this summer, but very slow at first, and then probably reach high-volume production around summer next year.

And then we’ll have Optimus 4, a design clean, next year. I try to release a new robot design every year, an improved robot design every year." $TSLA

via @Abundance360

[Tiberius @tiberiusfiles]

This interview is wild

The US left their bases in the Middle East exposed, and their allies, and their personnel — to send the defence systems to Israel

US troops died so the US could protect foreign citizens instead

What is this if not treason?

[Cashu Nate @cashunate]

X Money is about to onboard ~1 Billion people into the control grid..

[Elon Musk @elonmusk]

This will be big

[Elon Musk @elonmusk]

Congratulations to the Tesla team on making the first production Cybercab!